Lantern Pharma (LTRN) Reports Positive Efficacy Data of LP-284 in Hematologic Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. SPY
2. USO
3. META
4. MSFT
5. COST
6. MU
7. IONS
8. ORCL
9. RMR
10. LEVI

Go back to Lantern Pharma (LTRN) Reports Positive Efficacy Data of LP-284 in Hematologic Cancers
(NASDAQ: LTRN) Delayed: 3.35 +0.25 (8.06%)
Previous Close $3.10    52 Week High $ 
Open $3.14    52 Week Low $ 
Day High $3.37    P/E N/A 
Day Low $3.10    EPS $ 
Volume 339,870